Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Knockdown of Lingo1b protein promotes myelination and oligodendrocyte differentiation in zebrafish.
Copaxone
Polymorphism in Leptin and Leptin Receptor Genes May Modify Leptin Levels and Represent Risk Factors for Multiple Sclerosis.
Synergistic Effects of Reserve and Adaptive Personality in Multiple Sclerosis.
Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study.
Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study.
Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab.
Chronic Inflammatory Demyelinating Polyneuropathy Following Anti-TNF-α Therapy With Infliximab for Crohn's Disease.
Boxed warning of HBV risk added to Rituxan, Arezerra
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.
Comprehensive Immunophenotyping of CSF cells in relapsing-remitting multiple sclerosis patients with daclizumb therapy
Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9.
Multiple sclerosis and risk of young-adult-onset Hodgkin lymphoma.
Guillain-Barré Syndrome (42 Cases) Occurring During a Zika Virus Outbreak in French Polynesia.
Primary Progressive MS evolving from Radiologically Isolated Syndrome.
Regulatory T Cells Contribute to the Inhibition of Radiation-Induced Acute Lung Inflammation via Bee Venom Phospholipase A₂ in Mice.
Correction: Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
AB Science confirms the filing for the Marketing Authorization Application to the European Medicines Agency of masitinib in the treatment of pancreatic cancer
Charcot-Marie-Tooth 1A: a narrative review with clinical and anatomical perspectives.
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis.
Epigenetic modifications of Dexras 1 along the nNOS pathway in an animal model of multiple sclerosis.
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
Two cases of relapses in primary progressive multiple sclerosis after fingolimod withdrawal.
The Role of Endogenous IFN-β in the Regulation of Th17 Responses in Patients with Relapsing-Remitting Multiple Sclerosis.

Pages